Wall Street Zen downgraded shares of Healthpeak Properties (NYSE:DOC - Free Report) from a hold rating to a sell rating in a research note released on Monday.
Several other analysts also recently weighed in on DOC. Robert W. Baird lowered their target price on Healthpeak Properties from $24.00 to $22.00 and set an "outperform" rating for the company in a research note on Tuesday, April 29th. Scotiabank cut their target price on shares of Healthpeak Properties from $23.00 to $21.00 and set a "sector outperform" rating on the stock in a research note on Monday, May 12th. Wells Fargo & Company cut their target price on shares of Healthpeak Properties from $22.00 to $20.00 and set an "equal weight" rating on the stock in a research note on Monday, June 2nd. Argus restated a "buy" rating and issued a $25.00 target price on shares of Healthpeak Properties in a research note on Tuesday, April 29th. Finally, Evercore ISI cut their target price on shares of Healthpeak Properties from $23.00 to $21.00 and set an "outperform" rating on the stock in a research note on Monday, April 28th. One analyst has rated the stock with a sell rating, two have assigned a hold rating and nine have given a buy rating to the company. According to data from MarketBeat.com, Healthpeak Properties has an average rating of "Moderate Buy" and an average price target of $23.27.
View Our Latest Research Report on Healthpeak Properties
Healthpeak Properties Stock Up 1.5%
Healthpeak Properties stock traded up $0.28 during trading on Monday, reaching $18.54. 6,325,322 shares of the company's stock were exchanged, compared to its average volume of 5,359,315. The company's 50-day moving average is $17.46 and its two-hundred day moving average is $18.98. The company has a debt-to-equity ratio of 1.01, a quick ratio of 1.35 and a current ratio of 1.35. Healthpeak Properties has a 52-week low of $16.64 and a 52-week high of $23.26. The firm has a market cap of $12.88 billion, a price-to-earnings ratio of 46.34, a PEG ratio of 2.08 and a beta of 1.03.
Healthpeak Properties (NYSE:DOC - Get Free Report) last announced its earnings results on Thursday, April 24th. The real estate investment trust reported $0.46 earnings per share for the quarter, meeting the consensus estimate of $0.46. The company had revenue of $702.89 million during the quarter, compared to the consensus estimate of $690.76 million. Healthpeak Properties had a return on equity of 3.06% and a net margin of 9.99%. The company's revenue was up 15.9% on a year-over-year basis. During the same period last year, the firm earned $0.45 earnings per share. On average, analysts predict that Healthpeak Properties will post 1.86 earnings per share for the current year.
Healthpeak Properties Announces Dividend
The business also recently announced a monthly dividend, which will be paid on Tuesday, September 30th. Shareholders of record on Friday, September 19th will be given a $0.1017 dividend. The ex-dividend date of this dividend is Friday, September 19th. This represents a $1.22 dividend on an annualized basis and a yield of 6.58%. Healthpeak Properties's payout ratio is 305.00%.
Insiders Place Their Bets
In related news, Director Tommy G. Thompson bought 5,777 shares of the business's stock in a transaction on Wednesday, May 28th. The stock was bought at an average price of $17.27 per share, for a total transaction of $99,768.79. Following the transaction, the director directly owned 144,290 shares in the company, valued at $2,491,888.30. This represents a 4.17% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO Scott M. Brinker purchased 2,750 shares of the business's stock in a transaction dated Friday, May 9th. The shares were acquired at an average price of $17.39 per share, for a total transaction of $47,822.50. Following the acquisition, the chief executive officer directly owned 204,613 shares in the company, valued at $3,558,220.07. This represents a 1.36% increase in their position. The disclosure for this purchase can be found here. Insiders purchased a total of 29,764 shares of company stock worth $521,909 in the last quarter. 0.23% of the stock is currently owned by corporate insiders.
Institutional Inflows and Outflows
A number of hedge funds and other institutional investors have recently bought and sold shares of DOC. Jones Financial Companies Lllp grew its position in Healthpeak Properties by 21.5% in the 4th quarter. Jones Financial Companies Lllp now owns 11,963 shares of the real estate investment trust's stock worth $242,000 after purchasing an additional 2,118 shares during the last quarter. Steward Partners Investment Advisory LLC lifted its holdings in shares of Healthpeak Properties by 22.4% during the 4th quarter. Steward Partners Investment Advisory LLC now owns 5,450 shares of the real estate investment trust's stock worth $110,000 after acquiring an additional 998 shares during the period. Assetmark Inc. lifted its holdings in shares of Healthpeak Properties by 433.5% during the 4th quarter. Assetmark Inc. now owns 2,982 shares of the real estate investment trust's stock worth $60,000 after acquiring an additional 2,423 shares during the period. Atria Investments Inc lifted its holdings in shares of Healthpeak Properties by 17.5% during the 4th quarter. Atria Investments Inc now owns 52,516 shares of the real estate investment trust's stock worth $1,064,000 after acquiring an additional 7,806 shares during the period. Finally, Proficio Capital Partners LLC bought a new position in shares of Healthpeak Properties during the 4th quarter worth about $1,086,000. 93.57% of the stock is currently owned by institutional investors and hedge funds.
Healthpeak Properties Company Profile
(
Get Free Report)
Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.
Read More

Before you consider Healthpeak Properties, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Healthpeak Properties wasn't on the list.
While Healthpeak Properties currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.